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Analysis of Inelastic Interactions for Therapeutic
Proton Beams Using Monte Carlo Simulation
Anatoly B. Rosenfeld, Senior Member, IEEE, Andrew J. Wroe, Iwan M. Cornelius, Member, IEEE,
Mark Reinhard, Member, IEEE, and Dimitri Alexiev, Member, IEEE
Abstract—The irradiation of various tissue-like materials by
therapeutic proton beams was simulated using Monte Carlo.
The contribution of inelastic reaction products to the depth-dose
distribution was determined. The use of silicon microdosimeters
for verifying Monte Carlo calculations was also investigated.
The importance of these studies to Monte Carlo-based treatment
planning systems is emphasized.
I. INTRODUCTION
PROTON therapy is offering highly conformal radiotherapytreatment, which is based on specific properties of depth-
dose deposition by energetic protons in a medium. The energies
of protons utilized in proton therapy are around 60 MeV for
the treatment of eye tumors and up to 250 MeV for deep-seated
tumors.
For accurate conformal treatment of the target volume, it is
important to have treatment-planning systems that are able to
simulate precisely the interaction of the primary proton beam
within the body. Taking into account an electron density dis-
tribution in a target volume obtained from a CT scan, the CT
numbers may not be adequate for the planning of heterogeneous
targets. Errors in the dose distribution and proton range can be
encountered for different target materials if proton inelastic re-
actions are not considered as part of the absorbed dose simu-
lations [1]. Dose planning systems based on Monte Carlo sim-
ulations would be optimal for calculating dose distributions in
heterogeneous targets if the composition of the target is known.
Recently, several groups have studied Monte Carlo ap-
proaches for dose planning in proton therapy. A simplified
Monte Carlo approach was proposed for dose planning in
heterogeneous targets [2]. However, verification of this plan
was achieved by the conversion of doses in a body to the
dose distribution in water with verification of the latter. It
was demonstrated that the agreement between simulated and
measured doses in water is not a guarantee of correct dose
distribution within the body.
The dose distribution verification should be done in a
phantom containing realistic heterogeneities. In many cases
of proton therapy treatment, the highly conformal absorbed
dose distributions do not guarantee the best treatment outcome
particularly in case of the spread out Bragg peak (SOBP). It has
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been demonstrated that a variable radiobiological effect (RBE)
could be implemented in a clinical proton treatment planning
system, for use particularly when the target is close to critical
organs [3]; however, further development of radiobiological
models is required. This means that dose planning in proton
therapy could be conducted utilizing an RBE-based Monte
Carlo treatment planning system in a medium with well-known
composition. Such a system would employ the appropriate
radiobiological models when primary and secondary charged
particle spectra are known.
In this paper, we investigate the importance of inelastic proton
scattering on an absorbed dose distribution and proton ranges in
different tissues using the GEANT4 Monte Carlo simulation kit.
We also investigate the potential use of silicon microdosimetry
for Monte Carlo verification, a technique that does not require
tissue equivalence of the dosimeter.
II. SIMULATION OF ABSORBED DOSES
IN A PROTON THERAPY BEAM
Simulations were carried out for monoenergetic 60- and
200-MeV proton beams within homogeneous: water, A-150
tissue equivalent plastic, adipose (ICRP), bone (ICRP), and
muscle (ICRP) phantoms. Each energy/tissue combination
was first simulated neglecting inelastic scatter and then with
the inclusion of inelastic scatter. A comparison between the
depth-dose distributions for these scenarios provided important
information on the importance of inelastic scatter interactions.
A. Simulation Parameters
The GEANT4 Monte Carlo Transport Toolkit (version 4.5.2)
[4] was used to simulate depth-dose depositions within homo-
geneous phantoms. The phantom geometry consisted of a rect-
angular prism with sensitive slices covering the cross sectional
area of the phantom (Fig. 1). The sensitive slices 5–10 m in
thickness were separated by gaps of 0.1–1 mm. The cross sec-
tional area of the sensitive slices was 5 5 cm. This provides an
adequate cross sectional area for pencil beam depth-dose dis-
tributions as well as for small area broad beams. In total, 320
sensitive slices were employed at regular intervals within the
phantom to provide adequate resolution of the depth-dose dis-
tribution.
The inelastic scattering model employed in this investigation
was the G4PreCompound model and is considered suitable for
the therapeutic energy range [5]. The G4PreCompound model
accounts for the production of secondary particles as a result
of inelastic scatter, including the generation of charged secon-
daries, neutrons, and photons. The elemental composition, and
0018-9499/04$20.00 © 2004 IEEE
3020 IEEE TRANSACTIONS ON NUCLEAR SCIENCE, VOL. 51, NO. 6, DECEMBER 2004
Fig. 1. Schematic representation of the phantom used in the depth-dose
simulations. It is important to note the production of secondaries as a direct
result of inelastic nuclear interactions of protons within the phantom.
relative isotopic abundances, of phantom materials were ob-
tained using an ICRU based program [6].
To determine the dose as a function of depth, the energy de-
posited by every particle (whether this be primary or secondary)
within a sensitive volume was simulated. This was achieved
by tracking the energy depositions from both primary and sec-
ondary particles in each slice for a single incident proton history.
These energy depositions were summed to provide the total en-
ergy deposited within the slice for a given history. Upon com-
pletion of the simulation, the total energy deposition in each sen-
sitive slice was determined. From this information the absorbed
dose deposited as a function of depth could be ascertained.
In order to determine the effect that inelastic scatter has on
the depth-dose distribution, the simulation would initially be
run without taking into account inelastic scatter and then again
with identical parameters taking inelastic scatter into account.
The depth-dose distributions for both would then be compared.
This comparison was based on parameters such as the peak to
entrance dose ratio, the integral dose, the Bragg peak position,
and the entrance dose.
B. Results
For verification of the Monte Carlo simulation, GEANT
4 code simulations of the absorbed dose for a 160.7 MeV
proton beam of 0.8035 MeV within a homogeneous water
phantom were compared with GEANT4 simulation data sup-
plied by H. Paganetti from the North-Eastern Proton Therapy
Centre (NEPC), Massachusetts General Hospital (MGH),
Boston. The simulation data supplied by Paganetti utilized
the same incident beam properties. The phantom consisted of
a homogeneous water tank with a 10-mm-thick Perspex lid.
The GEANT4 simulation of Paganetti has undergone extensive
experimental verification at NPTC and can be considered to be
a good benchmark for dose distributions in water. Fig. 2 shows
the relationship between both sets of data.
Excellent agreement was found between the two data series
for Bragg peak position, FWHM, plateau dose and distal edge.
A slight shift in the Bragg peak was observed and no verified
simulation data was supplied by H. Paganetti in the first 10 mm
of the distribution due to a 10-mm-thick Perspex lid situated at
the start of the water tank. The shift in Bragg peak, while small,
was accounted for using the differences in the relative stopping
power between water and Perspex [6] for the first 10 mm. When
this was applied, the peak positions were found to be almost
identical. Similar verification simulations were conducted for
incident protons from three independent sources with energies
of 60, 200, and 250 MeV. In all cases, the GEANT4.5.2 simu-
lation compared extremely well. As such, it can be concluded
from this analysis that the Monte Carlo simulation using the
GEANT4.5.2 code has undergone preliminary verification in the
mean clinical energy range.
Figs. 3 and 4 show the effect of inelastic scattering on the dose
distribution in different phantom materials for monoenergetic
60 and 200 MeV proton beams, respectively.
Results for both proton energies clearly demonstrated the ef-
fect of composition of the phantom on Bragg peak position
(Table I). Additionally, the role of inelastic scattering can be
seen in the amplitude (shape) of the Bragg peak when inelastic
interactions have been taken into account in the absorbed dose
simulations. This difference became much more pronounced
with increasing proton energy. The results on range, the ratio
of the peak-to-entrance dose for different materials, with and
without inelastic scattering, are presented in Tables II and III.
It is clear from the 60 and 200 MeV results that there is indeed
an effect not only on the range of the protons within the phantom
as a result of the composition, but also a difference in the in-
elastic scatter component. In the case of the 60-MeV protons,
the difference in the Bragg peak position was approximately 14
mm across the simulated materials. In the case of the 200-MeV
proton beam, this effect was measured at almost 120 mm. It was
established that the stopping power determined the range of the
primary protons within different materials. This parameter is al-
ready included in many treatment planning systems to identify
any differences in range that is encountered as a result of a het-
erogeneous patient geometry. However, this research highlights
the importance of the inclusion of accurate geometry composi-
tional information as errors in composition can result in large
difference of the position of the Bragg Peak within the phantom
or patient.
As the incident proton energy increased, the effect of inelastic
scatter on the key output parameters also increased. A degrada-
tion in peak to entrance dose ratio was observed to be around
a 5%–8% for 60-MeV protons and over 30% for a 200 -MeV
beam. Taking into account that the inelastic cross section de-
pends on the proton energy and the composition of the target,
the effect will be dominated by different materials under dif-
ferent proton energies. At 60 MeV, the material displaying the
greatest effect was A-150, while at 200 MeV the most effected
material was muscle.
The phantom material also affects the spectra of secondary
particles produced via inelastic scatter. It is clear from Table IV
that when we consider the difference in integral dose, muscle
has the highest discrepancy between the simulation where
inelastic scatter was considered and the simulation where it
was ignored. This is a direct result of muscle producing more
long-range secondaries, such as neutrons and photons, which
carry dose out of the sensitive slices and away from the incident
protons track. These results highlight the need for the inclusion
of accurate material compositions and the cross sections of
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Fig. 2. Comparison of verified simulation data supplied by Dr. Paganetti and GEANT4.5.2 simulation utilized in this investigation for a 160.7-MeV proton beam
incident on a water phantom.
Fig. 3. Comparison of depth-dose distributions for a monoenergetic 60-MeV proton beam in different phantom materials.
inelastic reactions within the treatment planning systems. The
cross sections of inelastic scatter and the spectra of secondary
particles appeared to not only change between materials, but
also with incident proton energy. It is important to mention
that uncertainty in inelastic cross sections will effect dose
distributions in phantom materials.
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Fig. 4. Comparison of depth-dose distributions for a monoenergetic 200-MeV proton beam in different phantom materials.
TABLE I
ELEMENTAL COMPOSITIONS BY RELATIVE ABUNDANCE FOR THE MATERIALS CONSIDERED [6]
While it has been shown that inelastic products effect the
depth-dose distribution of the therapeutic proton beam within
different materials, the biological effect of these secondaries
should also be taken into account utilising RBE if a biological
model is part of planning system.
III. VERIFICATION OF MONTE CARLO SIMULATIONS
USING SILICON MICRODOSIMETRY
If future treatment planning systems are based on full Monte
Carlo simulations that provide absorbed and biological dose dis-
tributions, verification of all secondaries is an important issue
for quality assurance (QA). The idea of verifying a complicated
mixed radiation field in a phantom simulated by Monte Carlo
using MCNP code by measurements of the absorbed dose in
emended material which is different to the phantom has been
proposed by Rosenfeld and implemented in epithermal boron
neutron capture therapy (BNCT) [7]. This method has been used
to measure the displacement kinetic energy released in a mass
(KERMA) in Si, which is possible through the changing elec-
trical parameters of a Si diode used as a measure of the cumula-
tive effect of a mixed radiation field. For verification of Monte
Carlo simulations in proton therapy, measurements of the pat-
tern of single events of deposition energy by secondary particles
will be advantageous in comparison with the measurement of a
cumulative effect as in BNCT [7], [8].
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TABLE II
BRAGG PEAK POSITION, THE RATIOS OF PEAK TO ENTRANCE DOSES (WITH
AND WITHOUT INELASTIC SCATTER), AND THE RELATIVE DIFFERENCE
IN THIS RATIO FOR 60-MeV DEPTH-DOSE DISTRIBUTIONS
TABLE III
BRAGG PEAK POSITION, THE RATIOS OF PEAK TO ENTRANCE DOSES (WITH
AND WITHOUT INELASTIC SCATTER), AND THE RELATIVE DIFFERENCE
IN THIS RATIO FOR 200-MeV DEPTH DOSE-DISTRIBUTIONS.
TABLE IV
INTEGRAL DOSES WITH AND WITHOUT INELASTIC SCATTERING AND THE
RELATIVE DIFFERENCE FOR 200 MeV DEPTH DOSE DISTRIBUTIONS.
INTEGRAL DOSE IN CGY PER 200 000 PROTONS
A promising tool for this purpose could be silicon micro-
dosimetry instrumentation, which was developed at Centre for
Medical Radiation Physics, University of Wollongong, Wol-
longong, Australia, and tested in neutron and proton therapy
applications [9]–[11]. The silicon microdosimeter is based on
an array of sensitive micron-size silicon volumes in which de-
posited energy from each event can be measured. Silicon mi-
crodosimeters may be incorporated into the Monte Carlo calcu-
lations used by future treatment planning systems. In this situa-
tion, the role of silicon microdosimetry in proton therapy can be
revised. By comparing the experimental and theoretical energy
deposition spectra one can refine the model of the primary beam,
components of the geometry such as beam modifying devices,
the patient, the detector, or the physical models of the interaction
of the former with the latter. Tissue equivalency of the detector
system is not required in the proposed approach. Validation of
this method was investigated at NPTC under a 230-MeV proton
beam [9].
A. Method of Simulation and Experiment
The facility at NPTC uses a cyclotron to accelerate a proton
beam to an initial energy of 230 MeV. The beam then passes
Fig. 5. Depth-dose distribution for the proton beam used in this study.
through a range modulator filter to create the desired spread
in the Bragg peak. A double scattering system using a fixed
scatterer and a second nonuniform thickness scatterer produce
a beam with a uniform intensity in the lateral profile over a
10 10 cm field size. The microdosimeter was placed at a
number of depths along the Bragg curve in a water phantom
and the spectra of energy deposition events were acquired. Mea-
surements were performed with 10- m-thick silicon-on-insu-
lator (SOI) devices to maximize the signal to noise ratio. These
results demonstrated the high resolution of the silicon micro-
dosimeter and the ability to operate at beam currents typically
used in clinical therapy. Fig. 5 shows the dose distribution mea-
sured with an ionizing chamber and the point of measurement
within the silicon microdosimeter at different depths in a water
phantom.
Owing to the restriction on computation times is necessary to
separate the simulation of these measurements into two; the first
simulated the passage of the primary beam through the beam
modifying devices and calculated the distribution of transmitted
proton energies. The second used the energy spectrum derived
from the first to transport the beam through the phantom and
microdosimeter probe.
1) Simulation of Beam Modifying Devices: A stack of right-
angled parallelepiped (RPP) volumes forms a simplified model
of the beam modifying devices (see Fig. 6), as follows: 1) lead
beam scatterer; 2) lead range modulator; 3) carbon range modu-
lator; 4) beam spreader; 5) transmission ion chamber; 6) nozle;
7) phantom wall is shown. The materials used in this simula-
tion enabled an energy spectrum of the incident proton beam to
be determined. The spread of the transmitted beam was simu-
lated and a gaussian fit was determined from the simulated re-
sults. From this relationship the mean energy was estimated to
be 192.4 MeV while 1.24 MeV and for the primary pencil
beam of energy 230.5 and 0.41 MeV. This simulation pro-
vided the beam characteristics that would determine the param-
eters of the incident beam onto the phantom geometry in the
second simulation.
2) Simulation of Phantom and Microdosimeter: The sil-
icon sensitive volume was modeled as a single right-angled
parallelepiped of dimensions 4800 1600 10 m . The
charge collection efficiency was 0.8, as was derived in previous
research [11]. The complicated device overlayer geometry was
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Fig. 6. Model of beam modifying devices used in GEANT4 simulation (1.
lead, 1.31 mm; 2. lead, 4.52 mm; 3. graphite, 0.7753 mm; 4. water, 36.5 mm; 5.
water, 3.04 mm; 6. air 2550 mm; 7. perspex, 10 mm).
Fig. 7. Model of phantom and detector geometry used in the GEANT4
simulation (1. water phantom; 2. Perspex probe holder; 3. aluminum shield; 4.
Perspex converter; 5. air gap; 6. silicon volume and overlayer).
simplified to a 1 m thickness SiO2 layer. The 300 m air
gap between the surface of the silicon microdosimeter and the
Perspex converter was also modeled, along with the 3.5-mm
Perspex converter, 0.4-mm-thick aluminum shield, 6-mm probe
holder, and a thickness of water corresponding to the depth of
measurement. This structure is displayed in Fig. 7. Simulations
were made for phantom thickness of 10, 188, 220, 227, 238,
and 248 mm. The location of these depths along the bragg peak
can be seen in Fig. 5 and [9]. The lateral dimensions of the
water phantom and other materials were set as twice the width
of the silicon sensitive volume.
The primary beam was modeled as a pencil beam that is nor-
mally incident on the surface of the phantom. This beam was
assumed to have a Gaussian distribution in energy determined
from the first simulation of the passage of protons through beam
modifying devices. The number of protons used in each simu-
lation was for depths of measure-
ments of 10, 188, 220, 227, 238, and 248 mm, respectively. The
charged secondaries were modeled using the G4PreCompound
Model and were only tracked if their residual range in material
was greater than 1 m. Electrons and gamma photons were only
Fig. 8. Spectra of energy deposited in the silicon microdosimeter at 10-mm
depth in water phantom.
Fig. 9. Spectra of energy deposited in the silicon microdosimeter at 227-mm
depth in water phantom.
tracked if their residual range in the medium was greater than
10 cm.
If a charged particle traversed the sensitive volume of the de-
tector the ionization energy lost in the sensitive volume was cal-
culated. Energy lost in the sensitive volume was assumed to be
equal to energy deposited and this energy deposition event was
tallied. The statistics of electron hole generation were ignored.
B. Results
Figs. 8 and 9 show an example of the simulated spectra of
deposited energies in the silicon microdosimeter at depths of
10 mm (entrance region) and 227 mm (Bragg peak region).
These results were compared with experimentally measured
data. First, the experimental results were not available below
10 keV owing to the noise threshold of the microdosimeter.
Agreement between the two curves in Fig. 8 in the region
10–60 keV is evident however the two curves depart for events
greater than this value. The simulation spectrum extends to
energies of 500 keV whereas the experimental results extend
beyond 1 MeV. This may be a result of the limited statistics
available for the simulated data. The beam was considered
normally incident onto the phantom and at this shallow depth
the angular distribution of protons may be narrower than the
actual distribution. Oblique strikes to the microdosimeter, and
hence, high-energy deposition events are unlikely in this model.
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In the real situation, however, the beam is not normally incident
but possesses some angular distribution that would serve to
broaden the angular distribution of protons at depth, increasing
the occurrence of oblique strikes.
At 227 mm, the peak in the simulated results was found to
shift further to higher energies as expected for reduced proton
energy. In this situation, the curves agree reasonably well in
the region 50–500 keV. The discrepancy between the curves ex-
ists at low values of energy deposition around 10–50 keV. It is
possible that this discrepancy is associated with an underesti-
mation of the gamma field due to simplification of the beam
modification process. Discrepancies under higher deposited en-
ergies could possibly be associated with simplification of micro-
dosimeter overlayer in thickness and in composition and angular
distribution of incident protons.
IV. CONCLUSION
Inelastic products have been shown to be an important con-
sideration to the depth-dose distribution of therapeutic proton
beams. Different phantom materials produce different levels of
inelastic scatter and different inelastic products. The spectra of
secondary particles and the cross section for inelastic scatter
also change as a function of energy. Thus, accurate patient ge-
ometry and the composition of this geometry needs to be accu-
rately input into the treatment planning system along with the
energy of the incident beam. Secondary radiations also need to
be tracked and their effect noted. This can be achieved using
Monte Carlo based treatment planning systems that utilize par-
allel computing techniques to provide clinically acceptable sim-
ulation times.
Simulations of energy deposition from single events of pri-
mary and secondary radiation in silicon microdosimeter mea-
surements in proton therapy were performed using the GEANT4
Monte Carlo toolkit. Significant discrepancies were observed
between simulated and experimental data. Future simulations
should be performed to model the beam modifying devices in
detail. This should include detailed geometry and composition
of beam modifying devices and diagnostics. In this situation, the
primary and secondary radiation field, particularly at shallower
depths, could be more accurately modeled. Future works will
be conducted in the modeling of neutron and electron contami-
nation of beam from beam modification devices. Incorporating
such a detailed model would however severely lengthen calcu-
lation time. Further work is, therefore, necessary to investigate
parallel computing possibilities for Monte Carlo calculations for
proton therapy.
Simulation results were analyzed to study the importance of
particles originating from inelastic interactions within the sil-
icon volume. These events were not seen to be important for a
proton therapeutic beam. This means that this method can be
applied accurately for verification of an external radiation field
generated in a phantom, i.e., outside the silicon volume of the
microdosimeter. In this situation, if the microdosimeter is to be
applied to proton therapy with the aim of making tissue equiv-
alent microdosimetric spectra, then a simple scaling factor may
suffice as was proposed in [10]. This is because there is no need
to subtract theoretical events contributing to microdosimetric
spectra from high LET products generated within the Si sen-
sitive volume as a result of interaction of protons with silicon.
Future experimental measurements should be performed in
heterogenous phantoms with elemental compositions close to
human tissue such as those provided in ICRU44. The micro-
dosimeter probe design should be altered to remove all mate-
rial surrounding the microdosimeter, with the exception of alu-
minum shielding.
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